Linopirdine
Appearance
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H21N3O |
Molar mass | 391.465 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Linopirdine is a psychostimulant/nootropic, which has neuroprotective effects.[1][2] It acts as a potassium channel blocker, and releases acetylcholine, via modulation of nAChRs, which is probably responsible for its nootropic action.[3]
See also
References
- ^ Solntseva, EI.; Bukanova, IuV.; Skrebitskiĭ, VG. "[Memory and potassium channels]". Usp Fiziol Nauk. 34 (4): 16–25. PMID 14658300.
{{cite journal}}
: Cite has empty unknown parameter:|month=
(help) - ^ Xia, S.; Lampe, PA.; Deshmukh, M.; Yang, A.; Brown, BS.; Rothman, SM.; Johnson, EM.; Yu, SP. (2002). "Multiple channel interactions explain the protection of sympathetic neurons from apoptosis induced by nerve growth factor deprivation". J Neurosci. 22 (1): 114–22. PMID 11756494.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - ^ Dzhura, EV.; He, W.; Currie, KP. (2006). "Linopirdine modulates calcium signaling and stimulus-secretion coupling in adrenal chromaffin cells by targeting M-type K+ channels and nicotinic acetylcholine receptors". J Pharmacol Exp Ther. 316 (3): 1165–74. doi:10.1124/jpet.105.095570. PMID 16280412.
{{cite journal}}
: Unknown parameter|month=
ignored (help)